NSTEMI

Clinical trials for NSTEMI explained in plain language.

Never miss a new study

Get alerted when new NSTEMI trials appear

Sign up with your email to follow new studies for NSTEMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 2

Heart attack breakthrough? common drug may shield your heart from future failure

Disease control Recruiting now

This study is testing if dapagliflozin, a medication originally for diabetes, can help prevent heart failure in people who have just had a serious heart attack and have weakened heart function. About 450 participants will take either the drug or a placebo pill daily for six month…

Matched conditions: NSTEMI

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

NSTEMI

Get alerted when new NSTEMI trials appear

Heart attack breakthrough? common drug may shield your heart from future failure